<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04065880</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01505; ch19Lardinois</org_study_id>
    <nct_id>NCT04065880</nct_id>
  </id_info>
  <brief_title>Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation</brief_title>
  <official_title>Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative prolonged air leak (PAL), referring to the passage of air from the lung
      parenchyma into the pleural space, is one of the most frequent postoperative complications
      after lung resection. To control air leak, there are two different products certified since
      years: TachoSil® and Neoveil®. This study is to investigate the difference of TachoSil® and
      Neoveil® in patients with PAL.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Blinded participants and unblinded investigators and evaluators</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>time required till air leak closure has occurred (hours)</measure>
    <time_frame>end of the operation (0 hours) until removal of the chest tubes or re-operation in case of prolonged air leak (first postoperative day)</time_frame>
    <description>time interval between end of the operation (closure of the skin) and air leak closure (less than 30ml on the digitalized drainage system).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of air leak (binary outcome 0/1), i.e. air loss &gt; 30ml</measure>
    <time_frame>end of the operation (0 hours) until removal of the chest tubes or re-operation in case of prolonged air leak (first postoperative day)</time_frame>
    <description>Incidence of air leak (binary outcome 0/1), i.e. air loss &gt; 30ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensity of air leak (continuous outcome, ml)</measure>
    <time_frame>end of the operation (0 hours) until removal of the chest tubes or re-operation in case of prolonged air leak (first postoperative day)</time_frame>
    <description>Intensity of air leak (continuous outcome, ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of prolonged air leak (&gt;10 days) (binary outcome 0/1)</measure>
    <time_frame>assessed at 10th postoperative day</time_frame>
    <description>Incidence of prolonged air leak (&gt;10 days) (binary outcome 0/1)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Prolonged Air Leak</condition>
  <condition>Postoperative Air Leak</condition>
  <arm_group>
    <arm_group_label>TachoSil®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TachoSil® is a collagen sponge coated with the human coagulation factors fibrinogen and thrombin.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neoveil®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Neoveil® sheet made of polyglycolic acid (PGA). It is a biodegradable, thermoplastic and non-antigenic polymer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TachoSil®</intervention_name>
    <description>topical absorbable fibrin sealant patch applied directly on the lung area with air fistula.</description>
    <arm_group_label>TachoSil®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neoveil®</intervention_name>
    <description>bioabsorbable soft-tissue reinforcement material applied on the normal shape of the lung at the end of the operation.</description>
    <arm_group_label>Neoveil®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a pulmonary air leak following open lung surgery, regardless of whether
             an anatomical or atypical resection was performed

          -  Patients who are able to decide for themselves whether to participate in the study or
             not ( for example due to language problems, mental disorders, dementia of the
             participant)

          -  Patients who are not family member or employee of the investigator

        Exclusion Criteria:

          -  Inability to follow the procedures of the study, for example, due to language
             problems, mental disorders, dementia of the participant

          -  Enrolment of the investigator, his/her family members, employees and other dependent
             persons
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier Lardinois, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Thoracic Surgery, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Didier Lardinois, Prof. MD</last_name>
    <phone>+41 61 328 77 99</phone>
    <email>Didier.lardinois@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jelena Jankovic, Dr. MD</last_name>
    <phone>+41 61 328 61 08</phone>
    <email>Jelena.jankovic@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Thoracic Surgery, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Lardinois, Prof. MD</last_name>
      <phone>+41 61 328 77 99</phone>
      <email>Didier.lardinois@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Jelena Jankovic, Dr. MD</last_name>
      <phone>+41 61 328 61 08</phone>
      <email>Jelena.jankovic@usb.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 20, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>May 6, 2020</last_update_submitted>
  <last_update_submitted_qc>May 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung resection</keyword>
  <keyword>TachoSil®</keyword>
  <keyword>Neoveil®</keyword>
  <keyword>air leak closure</keyword>
  <keyword>drainage time</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

